Kamada Ltd
Symbol: KMDA (NASDAQ)
6.87
▼ (-0.94%) -0.065
Company Description:
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Key Stats
- Today's Open: $6.91
- Today's High: $6.93
- Today's Low: $6.85
- Today's Volume: 6.87K
- Yesterday Close: $6.93
- Yesterday High: $7
- Yesterday Low: $6.88
- Yesterday Volume: 65.82K
- Last Min Volume: 200
- Last Min High: $6.884
- Last Min Low: $6.865
- Last Min VWAP: $6.869
Company Profile
- Name: Kamada Ltd
- Website: https://www.kamada.com
- Listed Date: 2013-05-31
- Location: ,
- Market Status: Active
- CIK Number: 0001567529
- SIC Code:
- SIC description:
- Market Cap: $407.14M
- Round Lot: 100
- Outstanding Shares: 57.51M
- Asset Type: CS
RECENT FILINGS FOR KMDA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-02 | 6-K | View |
| 2025-08-13 | 6-K | View |
| 2025-08-11 | 6-K | View |
| 2025-08-06 | 6-K | View |
| 2025-06-17 | 6-K | View |
| 2025-06-05 | SCHEDULE 13G/A | View |
| 2025-05-14 | 6-K | View |
| 2025-05-07 | 6-K | View |
| 2025-05-05 | 6-K | View |
| 2025-03-24 | 6-K | View |
| 2025-03-19 | 6-K | View |
| 2025-03-05 | SCHEDULE 13G/A | View |
| 2025-03-05 | 20-F | View |
| 2025-03-05 | 6-K | View |
| 2025-02-26 | 6-K | View |
| 2025-01-22 | 6-K | View |
| 2025-01-08 | 6-K | View |
| 2024-12-11 | 6-K | View |
| 2024-11-14 | SC 13G/A | View |
| 2024-11-13 | 6-K | View |
Latest News on KMDA